PDF herunterladen
Facial Plast Surg 2003; 19(1): 113-130
DOI: 10.1055/s-2003-39131
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Management of Adult Facial Vascular Anomalies

David W. Low
  • Division of Plastic Surgery, Edwin and Fannie Gray Hall Center for Human Appearance, University of Pennsylvania School of Medicine, Philadelphia, PA
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Mai 2003 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Vascular anomalies are best classified by biologic behavior-active hemangiomas, and inactive vascular malformations. Hemangioma growth is restricted to infancy, but residual deformity may persist to adult life in the form of redundant skin, bulky fibrofatty tissue, and ectatic cutaneous vessels. Treatment largely consists of scar revision and laser photocoagulation of residual vascular pigmentation. Vascular malformations are present throughout life and can cause increasing facial distortion and disfigurement as capillaries, veins, lymphatics, and/or arteries further dilate and the facial features hypertrophy. A variety of treatment options include laser photocoagulation, sclerotherapy, embolization, and direct surgical excision, and often a combination of techniques yields improved results. In many cases, however, therapy is only palliative, and patients should be advised of the limitations of each treatment option to avoid unrealistic expectations and disappointing results.

KEYWORDS

Hemangioma - vascular malformation - port wine stain - venous malformation - lymphatic malformation - arteriovenous malformation - lasers - sclerotherapy

REFERENCES

  • 1 Mulliken J B, Rogers G F, Marler J J. Circular excision of hemangioma and purse-string closure: the smallest possible scar.  Plast Reconstr Surg . 2002;  109(5) 1544-1554
    PubMedGoogle Scholar
  • 2 Zide B M, Glat P M, Stile F L, Longaker M T. Vascular lip enlargement: hemangiomas-tenets of therapy.  Plast Reconstr Surg . 1997;  100(7) 1664-1673
    PubMedGoogle Scholar
  • 3 Zide B M, Glat P M, Stile F L, Longaker M T. Vascular lip enlargement: port-wine macrochelia-tenets of therapy based on normative values.  Plast Reconstr Surg . 1997;  100(7) 1674-1681
    CrossrefPubMedGoogle Scholar
  • 4 Derby L D, Low D W. Laser treatment of venous vascular malformations.  Ann Plast Surg . 1997;  38(4) 371-378
    PubMedGoogle Scholar
  • 5 Pappas Jr C D, Persky M S, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations.  Ear Nose Throat J . 1998;  77(11) 914-922
    PubMedGoogle Scholar
  • 6 Ogita S. The role of OK-432 in the treatment of lymphangiomas: http://www.asahi-net.or.jp/~VF6S-OGT/ok-432role. html, 2002
    Google Scholar
  • 7 Padwa B L, Hayward P G, Ferraro N F, Mulliken J B. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy.  Plast Reconstr Surg . 1995;  95(6) 951-960
    CrossrefPubMedGoogle Scholar
  • 8 Bradley J P, Zide B M, Berenstein A, Longaker M T. Large arteriovenous malformations of the face: aesthetic results with recurrence control.  Plast Reconstr Surg . 1999;  103(2) 351-361
    CrossrefPubMedGoogle Scholar
  • 9 Kirschner R E, Low D W. Treatment of pyogenic granulomas by shave excision and photocoagulation.  Plast Reconstr Surg . 1999;  104(5) 1346-1349
    PubMedGoogle Scholar
  • 10 The Proteus Foundation. What is Proteus syndrome? http://www.proteus-syndrome.org/html/about.html. 2002
    Google Scholar